Studied since the early 1990s, cerebrospinal fluid Aβ42 is the most established fluid marker for detecting early Alzheimer’s disease, yet trying to turn it into a clinically certified, broad-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback